Baron Silver Stevens Financial Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Baron Silver Stevens Financial Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,000	Closed	-$254K	–	136
2022 Q3	$254K	Buy	+1,000	New	+$8.84K	0.07%	76
2021 Q1	–	Sell	-1,000	Closed	-$9K	–	417
2020 Q4	$9K	Buy	+1,000	New	+$9.58K	﹤0.01%	273

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Baron Silver Stevens Financial Advisors's TEVA Position: Q4 2022 in Review

Baron Silver Stevens Financial Advisors sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2022, closing a stake of 1,000 shares — an estimated $254K sold.

Baron Silver Stevens Financial Advisors first reported a position in TEVA in Q4 2020 and held it in 2 quarters. The position peaked at $254K in Q3 2022. 421 funds tracked by Wall St. Rank hold TEVA as of Q4 2022.

Baron Silver Stevens Financial Advisors reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2022 after selling out during the quarter.
Baron Silver Stevens Financial Advisors sold 1,000 Teva Pharmaceutical Industries Limited shares in Q4 2022, an estimated $254K.
Baron Silver Stevens Financial Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q4 2020 and held it in 2 quarters.
Baron Silver Stevens Financial Advisors's Teva Pharmaceutical Industries Limited position peaked at $254K in Q3 2022.
421 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2022.

Based on Baron Silver Stevens Financial Advisors's 13F filing for Q4 2022, filed 30 Jan 2023.